0001104659-20-072556.txt : 20200611 0001104659-20-072556.hdr.sgml : 20200611 20200611210040 ACCESSION NUMBER: 0001104659-20-072556 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200609 FILED AS OF DATE: 20200611 DATE AS OF CHANGE: 20200611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alleva Lawrence M CENTRAL INDEX KEY: 0001553053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37368 FILM NUMBER: 20958635 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 3300 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptimmune Therapeutics PLC CENTRAL INDEX KEY: 0001621227 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 JUBILEE AVENUE STREET 2: MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RX BUSINESS PHONE: 44 1235 430000 MAIL ADDRESS: STREET 1: 60 JUBILEE AVENUE STREET 2: MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RX FORMER COMPANY: FORMER CONFORMED NAME: Adaptimmune Ltd DATE OF NAME CHANGE: 20141001 4 1 a4.xml 4 X0306 4 2020-06-09 0 0001621227 Adaptimmune Therapeutics PLC ADAP 0001553053 Alleva Lawrence M C/O ADAPTIMMUNE THERAPEUTICS PLC, 60 JUBILEE AVE, MILTON PARK ABINGDON X0 OX14 4RX UNITED KINGDOM 1 0 0 0 Ordinary Shares with a nominal value of GBP0.001 per share 2020-06-09 4 P 0 12900 1.89 A 12900 I Held by Trust Ordinary Shares with a nominal value of GBP0.001 per share 47280 I Held by Trust Ordinary Shares with a nominal value of GBP0.001 per share 70584 D The ordinary shares whose purchase is reported on this line are represented by American Depositary Shares ("ADS") and are held in the form of ADSs by the Lawrence M. Alleva Revocable Trust. Each ADS represents six ordinary shares of Adaptimmune Therapeutics plc. The 12,900 ordinary shares reported in Column 4 and Column 5 are represented by 2,150 ADSs. The price reported in Column 4 of $1.89 per ordinary share is derived from the purchase price paid on June 9, 2020 of $11.354 per ADS divided by six. The 47,280 ordinary shares reported in Column 5 are represented by 7,880 ADSs. These shares are held in the form of ADSs by the Lawrence M. Alleva Revocable Trust. The 70,584 ordinary shares reported in Column 5 are represented by 11,764 ADSs. These shares are held in the form of ADSs by Mr. Alleva. /s/ Lawrence M. Alleva 2020-06-11